SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 117 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,781,500 | -91.4% | 70,000 | -91.9% | 1.63% | -36.8% |
| Q3 2022 | $20,648,000 | +16.2% | 859,240 | -6.9% | 2.58% | +44.6% |
| Q2 2022 | $17,766,000 | -13.4% | 923,400 | -21.8% | 1.78% | +30.4% |
| Q1 2022 | $20,517,000 | -19.0% | 1,180,500 | +2.0% | 1.37% | -0.7% |
| Q4 2021 | $25,339,000 | +9.2% | 1,157,560 | -4.7% | 1.38% | +37.6% |
| Q3 2021 | $23,212,000 | -22.8% | 1,214,670 | -30.6% | 1.00% | -16.6% |
| Q2 2021 | $30,071,000 | -1.9% | 1,751,342 | +27.7% | 1.20% | +10.8% |
| Q1 2021 | $30,666,000 | +28.8% | 1,371,480 | +28.1% | 1.08% | +18.2% |
| Q4 2020 | $23,809,000 | +4912.4% | 1,070,550 | +3224.7% | 0.92% | +4731.6% |
| Q3 2020 | $475,000 | – | 32,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |